Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02659787 · ClinicalTrials.gov registry record · NA
Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT02659787 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 38 participants.
The verdict
NCT02659787, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
This study seeks to to study the effects of buprenorphine, a partial mu-opioid agonist, on depressed mood in a healthy young adults with a range of depressive symptomatology.
Interventions
- DRUG Placebo
- DRUG 0.2mg Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02659787
The ClinicalTrials.gov registry entry for NCT02659787 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02659787 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02659787 about?
NCT02659787 is a clinical study titled "Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology". This study seeks to to study the effects of buprenorphine, a partial mu-opioid agonist, on depressed mood in a healthy young adults with a range of depressive symptomatology.
What is the current status of trial NCT02659787?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2016-06. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02659787?
The interventions under investigation include: Placebo (DRUG), 0.2mg Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT02659787?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.